Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hung Hom, Hong Kong.
Disabil Rehabil. 2020 Apr;42(7):892-901. doi: 10.1080/09638288.2018.1510993. Epub 2019 Jan 7.
To identify the existing evidence evaluating the cost-effectiveness of physiotherapy treatments for people with neurological disorders. Multiple databases were searched from database inception until July 2018. Studies estimating the cost-effectiveness as incremental cost-effectiveness ratios, cost per quality-adjusted life year, cost per disability-adjusted life year and cost per other measurable results were included. Physiotherapy Evidence Database scale, and Consensus on Health Economic Criteria list were used for rating the quality of the evidence. Ten studies involving 1462 participants were included. Aerobic training, progressive strength training, and a pragmatic physiotherapy program (combination of stretching, strength, and balance training) were reported as potentially cost-effective for older adults with vascular cognitive impairment, falls prevention in Parkinson's disease and multiple sclerosis respectively. Physiotherapy as an adjuvant for pain control was also reported as cost-effective for reflex sympathetic dystrophy. One study testing extra physiotherapy-by-physiotherapy assistant in cerebral palsy and two studies testing extra therapy using a robotic arm and Wii therapy for hand rehabilitation in stroke were reported as not cost-effective. There are limited studies that have evaluated the cost-effectiveness of physiotherapy treatments in neurological disorders. Three studies that combined extra physiotherapy-by-physiotherapy assistant and novel interventions with conventional physiotherapy were found not cost-effective.Implications for RehabilitationProgressive muscle strengthening exercise over a period of 6-month is reported to be cost-effective for falls prevention in people with Parkinson's diseaseAerobic training is reported as potentially cost-effective for older adults with vascular cognitive impairmentPhysiotherapy given as an adjuvant treatment is reported to be potentially cost-effective for reflex sympathetic dystrophy of less than 1-year durationOne study reported physiotherapy involving static stretching, aerobic exercise, strengthening exercise, and balance training as cost-effective for people with multiple sclerosisAdditional physiotherapy-by-physiotherapy assistant or family member for improving motor development in cerebral palsy and the use of novel physiotherapy techniques such as robotics or Wii plus conventional physiotherapy for improving arm function in stroke are found not cost-effectiveGroup therapy for improving physical activity in mild Alzheimer's disease is found not cost-effective.
确定评估神经障碍患者物理治疗成本效益的现有证据。方法:从数据库建立开始到 2018 年 7 月,对多个数据库进行了检索。纳入了估计增量成本效益比、每质量调整生命年成本、每残疾调整生命年成本和每其他可衡量结果成本的成本效益研究。使用物理治疗证据数据库量表和健康经济标准清单对证据质量进行评分。结果:纳入了 10 项研究,涉及 1462 名参与者。有氧运动、渐进式力量训练和实用物理治疗方案(伸展、力量和平衡训练的组合)分别被报道为血管性认知障碍老年人、帕金森病和多发性硬化症患者的跌倒预防以及多发性硬化症患者的跌倒预防具有潜在成本效益。物理治疗作为反射性交感神经营养不良的辅助治疗也被报道具有成本效益。一项针对脑瘫的额外物理治疗助理和两项针对中风手康复的额外机器人手臂和 Wii 治疗的研究被报道为不具有成本效益。结论:目前,评估神经障碍患者物理治疗成本效益的研究有限。三项研究发现,额外的物理治疗助理和新的干预措施与常规物理治疗相结合没有成本效益。意义:常规物理治疗辅助治疗反射性交感神经营养不良少于 1 年的患者被报道具有潜在的成本效益。一项研究报道,为期 6 个月的渐进性肌肉强化运动对预防帕金森病患者跌倒具有成本效益。物理治疗作为辅助治疗被报道对血管性认知障碍老年人具有潜在的成本效益。对脑瘫患者进行额外的物理治疗助理或家庭成员治疗以改善运动发育,以及使用新型物理治疗技术(如机器人或 Wii 结合常规物理治疗)改善中风患者手臂功能的研究结果表明,这些方法并不具有成本效益。对轻度阿尔茨海默病患者进行团体治疗以提高身体活动能力的研究结果表明,这种方法不具有成本效益。